Biclustering of Adverse Drug Events in the FDA's Spontaneous Reporting System
暂无分享,去创建一个
G Hripcsak | R Rabadan | R Harpaz | R. Rabadán | G. Hripcsak | C. Friedman | R. Harpaz | H. Chase | H. Perez | H Perez | H S Chase | C Friedman | HS Chase
[1] Joseph M. Tonning,et al. Perspectives on the Use of Data Mining in Pharmacovigilance , 2005, Drug safety.
[2] Lehana Thabane,et al. Application of data mining techniques in pharmacovigilance. , 2003, British journal of clinical pharmacology.
[3] K. Solomons,et al. Toxicity with selective serotonin reuptake inhibitors. , 2005, The American journal of psychiatry.
[4] A. Fliri,et al. Analysis of drug-induced effect patterns to link structure and side effects of medicines , 2005, Nature chemical biology.
[5] William DuMouchel,et al. Bayesian Data Mining in Large Frequency Tables, with an Application to the FDA Spontaneous Reporting System , 1999 .
[6] E. Brown,et al. Effects of Coding Dictionary on Signal Generation , 2002, Drug safety.
[7] D. Classen,et al. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. , 1997, JAMA.
[8] Manfred Hauben,et al. ‘Extreme Duplication’ in the US FDA Adverse Events Reporting System Database , 2007, Drug safety.
[9] G. Niklas Norén,et al. Duplicate detection in adverse drug reaction surveillance , 2007, Data Mining and Knowledge Discovery.
[10] R. I. Breuer. Chlorpromazine hepatotoxicity manifested by a selective and sustained rise of serum alkaline phosphatase activity , 1965, The American Journal of Digestive Diseases.
[11] Lothar Thiele,et al. A systematic comparison and evaluation of biclustering methods for gene expression data , 2006, Bioinform..
[12] W. DuMouchel,et al. Novel Statistical Tools for Monitoring the Safety of Marketed Drugs , 2007, Clinical pharmacology and therapeutics.
[13] M. Hauben,et al. Data mining for signals in spontaneous reporting databases: proceed with caution , 2007, Pharmacoepidemiology and drug safety.
[14] D. Madigan,et al. The role of data mining in pharmacovigilance , 2005, Expert opinion on drug safety.
[15] A. Bate,et al. Quantitative signal detection using spontaneous ADR reporting , 2009, Pharmacoepidemiology and drug safety.
[16] George Hripcsak,et al. Automated encoding of clinical documents based on natural language processing. , 2004, Journal of the American Medical Informatics Association : JAMIA.
[17] Arlindo L. Oliveira,et al. Biclustering algorithms for biological data analysis: a survey , 2004, IEEE/ACM Transactions on Computational Biology and Bioinformatics.
[18] Eckart Zitzler,et al. BicAT: a biclustering analysis toolbox , 2006, Bioinform..
[19] S D Small,et al. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. , 1998, JAMA.
[20] R. O’Neill,et al. Use of Screening Algorithms and Computer Systems to Efficiently Signal Higher-Than-Expected Combinations of Drugs and Events in the US FDA’s Spontaneous Reports Database , 2002, Drug safety.
[21] Hans-Peter Kriegel,et al. Clustering high-dimensional data: A survey on subspace clustering, pattern-based clustering, and correlation clustering , 2009, TKDD.